Acute Kidney Injury in Pediatric Patients Treated with Vancomycin and Piperacillin-Tazobactam Versus Vancomycin and Cefotaxime: A Single-center Study

Background Previous literature showed a higher incidence of acute kidney injury (AKI) in pediatric patients using vancomycin + piperacillin-tazobactam compared to cefepime + vancomycin. Our aim was to compare the incidence of developing AKI during the use of vancomycin + cefotaxime with that during...

Descripción completa

Detalles Bibliográficos
Autores principales: Alqurashi, Rewaa, Batwa, Mawaddah, Alghamdi, Bashayer, Aljohani, Saja, Zaher, Nada, Alzahrani, Amal, Aldigs, Eman, Safdar, Osama
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2020
Materias:
Pediatrics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7047341/
https://www.ncbi.nlm.nih.gov/pubmed/32140363
http://dx.doi.org/10.7759/cureus.6805

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7047341/
https://www.ncbi.nlm.nih.gov/pubmed/32140363
http://dx.doi.org/10.7759/cureus.6805

Ejemplares similares